ion channel


Also found in: Dictionary, Thesaurus, Medical, Legal, Financial, Wikipedia.

ion channel

[′ī‚än ¦chan·əl]
(biophysics)
References in periodicals archive ?
Icagen partners with pharmaceutical and biotechnology companies to offer industry-leading scientific expertise and comprehensive access to technologies for ion channel and transporter drug discovery and development.
Sophion Qube is designed to reduce development time of drugs targeting ion channels, for indications like pain, epilepsy, bipolar disorder, depression and cystic fibrosis.
This crosstalk between the signalling pathways that activate the two different chloride ion channels now gives us a completely new therapeutic strategy to think about," said Foskett.
Although the true potential of ion channel blockers to help people with MS has not yet been reached, this strategy carries potential for stopping symptoms, restoring function and even protecting against nervous system damage in people with MS.
Products include the BioFlux[TM] system for studying cellular interactions, the IonFlux[TM] system for automated ion channel testing, and the IsoFlux[TM] system for circulating tumor cell analysis.
Select Ion Channel Modulator Drugs by Mode of Action II-3
Brown's significant scientific contributions to many areas of Safety Pharmacology, most notably contributions to ion channels and their relationship to human disease.
The IonFlux system tests ion channels by automating the traditional "patch clamp" technique, which allows the promising yet challenging ion channel drug target class to be screened in a physiologically relevant context.
Icagen is being re-launched to enable such companies to advance their ion channel and transporter drug discovery by bringing together the outstanding expertise of Icagen scientists with an unmatched portfolio of ion channel cell lines and assay technologies.
More recently, he uncovered the mechanism by which an ion channel opens and closes in response to a voltage across the membrane.
amp; CLEVELAND -- The Drug Safety Executive Council (DSEC), an industry membership association run by Cambridge Healthtech Associates (CHA), and ChanTest Corporation, the industry leading provider of ion channel and GPCR drug discovery tools and solutions, today announced the latest project for DSEC's Technology Evaluation Consortium.
NEW YORK, June 18, 2015 /PRNewswire/ -- This report analyzes the worldwide markets for Ion Channel Modulators in US$ Million.